Regulating Incremental Innovation in Medical Devices

The rapid evolution of medical devices through incremental design changes—with cardiac devices averaging 50 FDA applications over their regulatory lifespans—creates patient safety risks when these modifications are cleared without clinical testing. The authors call for active post-marketing surveillance linked to compulsory research.